home / stock / txg / txg news

TXG News and Press, 10x Genomics Inc.

Stock Information
Company Name: 10x Genomics Inc.
Stock Symbol: TXG
Market: NASDAQ
Website: 10xgenomics.com
Menu
TXG TXG Quote TXG Short TXG News TXG Articles TXG Message Board
Get TXG Alerts

News, Short Squeeze, Breakout and More Instantly...
TXG - 10x Genomics to Report First Quarter 2025 Financial Results on May 8, 2025

10x Genomics to Report First Quarter 2025 Financial Results on May 8, 2025 PR Newswire PLEASANTON, Calif. , April 14, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced it will report financial r...
TXG - 10x Genomics: Lower Cost Innovation May Drive A Rebound

2025-03-20 03:12:55 ET Summary I assign TXG a buy rating with a 1-year price target of $12.7 per share, projecting an 18% upside YoY. TXG's new lower-cost Chromium offerings could drive volume growth and increased adoption, particularly in the biopharma sector, presenting signific...

TXG - Stock selloff slashes needed-market cap for new Russell 2000 additions: Stephens

2025-03-13 08:00:20 ET More on the markets S&P, Nasdaq snap two-day rout after soft inflation CPI; Dow slips The Delta Dip Quantum Stocks: Seeking Alpha Analysts vs. Wall Street BlackRock sees upward pressure building on U.S., European bond yields ...

TXG - 10x Genomics gets injunction against Parse Biosciences' ATAC Products

2025-03-03 16:43:56 ET More on 10x Genomics 10x Genomics, Inc. (TXG) Q4 2024 Earnings Call Transcript 10x Genomics: Struggling Amid Operational Challenges 10x Genomics falls on quarterly EPS miss, 2025 revenue guidance concern 10x Genomics sees robust growth ...
TXG - 10x Genomics to Participate in the 45th Annual TD Cowen Health Care Conference

10x Genomics to Participate in the 45th Annual TD Cowen Health Care Conference PR Newswire PLEASANTON, Calif. , Feb. 18, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its ma...

TXG - 10x Genomics falls on quarterly EPS miss, 2025 revenue guidance concern

2025-02-13 10:33:00 ET More on 10x Genomics 10x Genomics, Inc. (TXG) Q4 2024 Earnings Call Transcript 10x Genomics: Struggling Amid Operational Challenges 10x Genomics sees robust growth across platforms in Q4 2023 10x Genomics GAAP EPS of -$0.40 misses by $0...

TXG - 10x Genomics sees robust growth across platforms in Q4 2023

2025-02-12 20:53:53 ET More on 10x Genomics 10x Genomics, Inc. (TXG) Q4 2024 Earnings Call Transcript 10x Genomics: Struggling Amid Operational Challenges 10x Genomics GAAP EPS of -$0.40 misses by $0.11, revenue of $165M in-line 10x Genomics, Harvard settle V...
TXG - 10x Genomics GAAP EPS of -$0.40 misses by $0.11, revenue of $165M in-line

2025-02-12 16:36:59 ET More on 10x Genomics 10x Genomics: Struggling Amid Operational Challenges 10x Genomics, Harvard settle Vizgen patent dispute Life sciences stocks fall on NIH funding concerns Seeking Alpha’s Quant Rating on 10x Genomics H...

TXG - Expected US Company Earnings on Wednesday, February 12th, 2025

Citius Pharmaceuticals Inc. (CTXR) is expected to report $-1.25 for Q1 2025 Casio Computer Co Ltd ADR (CSIOY) is expected to report for Q3 2025 Dundee Precious Metals Inc. (DPMLF) is expected to report $0.45 for Q4 2024 Elite Pharmaceuticals, Inc. (ELTP) is expected to report for Q3 2...

TXG - 10x Genomics Q4 2024 Earnings Preview

2025-02-11 17:35:59 ET More on 10x Genomics 10x Genomics: Struggling Amid Operational Challenges 10x Genomics, Harvard settle Vizgen patent dispute Life sciences stocks fall on NIH funding concerns Seeking Alpha’s Quant Rating on 10x Genomics H...
Next 10